Browse by Medical Category
Research at Mass General
Contact us by phone
The Center for Quantitative Health (CQH) in the Division of Clinical Research at Massachusetts General Hospital focuses on utilizing large data sets to develop strategies for probabilistic medicine and quantitative health.
We are currently recruiting patients with bipolar disorder or major depression to participate in a study of a mobile health application. Please call 617-643-6310 or email CEDD@partners.org to see if you might be eligible to participate in a study.
We believe that despite the incredible hype associated with big data, there is an opportunity to better serve our patients by developing tools for making clinically actionable predictions.
By facilitating the interaction of clinical and basic scientists at MGH and the broader community, and providing tools to do challenging but essential studies, CQH is intended to bridge the gap between large datasets and clinical application. It works closely with the MGH clinical and research programs, with the Clinical Trials Network and Institute (CTNI), and with translational programs such as the Psychiatric and Neurodevelopmental Genetics Unit (PNGU) and the Center for Genomic Medicine.
Roy Perlis, MD, MSc
Director, Center for Quantitative HealthProfessor of Psychiatry, Harvard Medical SchoolDr. Perlis is the director of the Center for Quantitative Health in the Department of Psychiatry at Massachusetts General Hospital, the Associate Director of the Psychiatric Genetics Program in Mood and Anxiety Disorders, and Professor of Psychiatry at Harvard Medical School.
He also serves as consultant to the American Psychiatric Association's bipolar treatment guidelines workgroup.
A graduate of Brown University, Harvard Medical School and Harvard School of Public Health, he completed his residency, chief residency, and clinical/research fellowship at Mass General before joining the faculty.
Dr. Perlis' clinical work and research is focused on difficult-to-treat or treatment resistant mood disorders, including major depressive disorder and bipolar disorder. He has authored more than 125 articles reporting original research, as well as numerous book chapters and reviews.
Current research efforts include identifying genetic variations which might predict treatment response, creating neuronal models of disease, and identifying and studying novel treatments for mood disorders.
His research has been supported by awards from NARSAD, NIMH, NSF, the American Philosophical Society, the Bowman Family Foundation, and the Stanley Center for Psychiatric Research, among others. In 2010 Dr. Perlis was awarded the Depression and Bipolar Support Alliance's Klerman Young Investigator Award.
Tom McCoy, MD
Director of Research, Center for Quantitative Health
Dr. McCoy attended Dartmouth College and Cornell Medical School before completing the MGH / McLean Psychiatry residency and an informatics fellowship in the Center for Experimental Drugs and Diagnostics. Dr. McCoy served as MGH Consult Psychiatry Chief Resident. He is currently Director of Research for the Center for Quantitative Health.
Kamber L. Hart
Clinical Research Coordinator, Center for Quantitative Health
Kamber graduated from Princeton University in 2016 with a AB in psychology. Her thesis focused on linguistic patterns of depression, specifically the use of metaphors in literature and personal accounts to describe the depressed state. Her goals are to apply to medical school and continue studying the intersection of language and mental health.
Amelia M. Pellegrini
Amelia graduated from Tufts University with a BA in Clinical Psychology and Spanish. She is from Bangor, Maine and is looking forward to spending the next few years in Boston before pursuing a Ph.D. in Clinical Psychology. She is particularly interested in investigating neuropsychological abnormalities in schizophrenia and other psychotic disorders.
Cristina Cusin, MD Staff Psychiatrist, Depression Clinical and Research Program, Massachusetts General Hospital Assistant Professor of Psychiatry, Harvard Medical School
Maurizio Fava, MD Executive Vice Chair, Department of Psychiatry, Massachusetts General Hospital Director, Division of Clinical Research, Mass General Research Institute Executive Director, Clinical Trials Network and Institute (CTNI) Associate Dean for Clinical and Translational Research, Slater Family Professor of Psychiatry, Harvard Medical School
Steve Haggarty, PhD Associate Investigator, Center for Genomic Medicine, Massachusetts General Hospital Associate Professor of Neurology, Harvard Medical School
Tracey Petryshen, PhD Center for Genomic Medicine, Massachusetts General Hospital Associate Professor of Psychology, Harvard Medical School Associate Member, Broad Institute Director, Harvard Catalyst ‘Omics Education Program
Joshua L. Roffman, MD, MMSc Co-Director for Psychiatric Neuroimaging, Massachusetts General Hospital Director of Research, Mass General Schizophrenia Clinical and Research Program Associate Professor of Psychiatry, Harvard Medical School
Jordan Smoller, MD, ScD Director, Psychiatric and Neurodevelopment Genetics Unit, Massachusetts General Hospital Co-Director, Genetics and Genomics Unit, Division of Clinical Research, Mass General Research Institute Professor of Psychiatry, Harvard Medical School
Center for Experimental Drugs & Diagnostics
Steven D. Sheridan, PhD
Dr. Sheridan has more than 15 years experience in both academia and industry deriving, expanding, differentiating and characterizing pluripotent and multipotent stem cells and their progeny for the purposes of disease modeling, genetic engineering, cell therapy, tissue engineering, and drug discovery. Currently a Senior Research Investigator and Director of the Platform for Cellular Modeling of Neuropsychiatric Disease in the Center for Human Genetic Research at Massachusetts General Hospital, he has also served as a Principal Scientist in biotech leading cross-functional teams in stem cell technology development.
Most recently, his research at MGH Center for Human Genetic Research (CHGR) involves the generation and characterization of human induced pluripotent stem cells (iPSCs), neural stem cells and neurons directly from patients of various neurodevelopmental and neuropsychiatric disease backgrounds (Fragile X syndrome, Rett Syndrome, CDKL5, Pitt-Hopkins Syndrome, Schizophrenia, Bipolar) in order to facilitate the development of novel cell based assays of disease mechanism.
He received his Ph.D. in Molecular Genetics at the University of California, Irvine and followed up with post-doctoral training in genetic engineering at Harvard University.
Jennifer Wang, PhD
Senior Research Scientist, Massachusetts General Hospital
Marion Joseph Riggs
Smita Jagtap, PhD
Smita Jagtap has earned her Ph.D degree in cell and molecular biology at University of Cologne, Germany. During her Ph.D, she worked on with hESC and hiPSC to develop toxicity assays and understand the molecular mechanisms of developmental toxicants such as retinoic acid, cytarabine and thalidomide. She worked on various differentiation protocols (neuronal, cardiomyocytes and hepatocyte-like cells) using hESC and hiPSC.
She is interested in the study of a rare X-linked genetic disorder CDKL5 (cyclin-dependent kinase-like 5) that results in early onset, difficult to control seizures, and severe neurodevelopmental impairment, with the goal of understanding the mechanisms and identifying novel targets. In particular, she would like to develop treatments selectively targeting diseased neurons by exploiting changes in neuronal metabolic potential during course of the disorder.
When not at work, Smita enjoys music, sketching and painting with urban sketchers.
B.S. in Biomedical Engineering, Boston University
Jeffrey previously did research in the Wong and Khalil lab at Boston University, studying conditionally dimerizable split protein systems using recombinases and CRISPR. He also did research at the Mount Sinai School of Medicine, where he researched biomarkers of inflammation in corneal epithelial cells. He is interested in studying genetic engineering and researching stem cell therapy in the future.
Jessica graduated with a BS in biology from Emmanuel College. Prior to joining the Perlis lab, she studied mood and autism spectrum disorders using animal models. In the long-term, she hopes to pursue a graduate degree and study the neurodevelopmental basis for mental illness. Her hobbies include scuba diving, manual photography and playing with her two dogs.
We are currently recruiting patients diagnosed with a variety of neuropsychiatric disorders, including depression, bipolar disorder, and schizophrenia.
Please call the research coordinator at 617-643-6310 or contact us by email to see if you might be eligible to participate in a study.
The purpose of this research study is to collect, process and store samples to do research on neuropsychiatric disorders. This research study looks at changes in the human body associated with neuropsychiatric disorders. Part of this study involves the collection of skin and blood samples that will be stored in a tissue bank for later use. Research using these samples will attempt to identify causes and what helps prevent, treat, or cure neuropsychiatric disorders. In addition, the samples collected for this study will be used for genetic research on these diseases.
Current and past CQH studies are supported by funding from NIMH, NARSAD, the National Science Foundation, AHRQ, the Stanley Center for Psychiatric Research at the Broad Institute, the American Philosophical Society, the Bowman Family Foundation, and the Sidney J. Baer, Jr. Foundation, as well as by industry partners including Proteus Biomedical.
For a PubMed listing of Dr. Perlis' articles, please click here.
Ravichandran C, Shinn AK, Öngür D, Perlis RH, Cohen B.Frequency of non-right-handedness in bipolar disorder and schizophrenia. Psychiatry Res. 2017 Jul;253:267-269.
Venkatesh KK, Castro VM, Perlis RH, Kaimal AJ.Impact of antidepressant treatment during pregnancy on obstetric outcomes among women previously treated for depression: an observational cohort study.J Perinatol. 2017 Jul 6.
McCoy TH, Hart KL, Perlis RH.Characterizing and predicting rates of delirium across general hospital settings.Gen Hosp Psychiatry. 2017 May;46:1-6.
Venkatesh KK, Kaimal AJ, Castro VM, Perlis RH.Improving discrimination in antepartum depression screening using the Edinburgh Postnatal Depression Scale.J Affect Discord. 2017 May;214:1-7.
Pavlova B, Perlis RH, Mantere O, Sellgren CM, Isometsä E, Mitchell PB, Alda M, Uher R.Prevalence of current anxiety disorders in people with bipolar disorder during euthymia: a meta-analysis.Psychol Med. 2017 Apr;47(6):1107-1115.
García-González J, Tansey KE, Hauser J, Henigsberg N, Maier W, Mors O, Placentino A, Rietschel M, Souery D, Žagar T, Czerski PM, Jerman B, Buttenschøn HN, Schulze TG, Zobel A, Farmer A, Aitchison KJ, Craig I, McGuffin P, Giupponi M, Perroud N, Bondolfi G, Evans D, O'Donovan M, Peters TJ, Wendland JR, Lewis G, Kapur S, Perlis R, Arolt V, Domschke K; Major Depressive Disorder Working Group of the Psychiatric Genomic Consortium, Breen G, Curtis C, Sang-Hyuk L, Kan C, Newhouse S, Patel H, Baune BT, Uher R, Lewis CM, Fabbri C.Pharmacogenetics of antidepressant response: A polygenic approach.Prog Neuropsychopharmacol Biol Psychiatry. 2017 Apr 3;75:128-134.
McCoy TH Jr, Chaukos DC, Snapper LA, Hart KL, Stern TA, Perlis RH.Enhancing Delirium Case Definitions in Electronic Health Records Using Clinical Free Text. Psychosomatics. 2017 Mar - Apr;58(2):113-120.
Bigdeli TB, Ripke S, Peterson RE, Trzaskowski M, Bacanu SA, Abdellaoui A, Andlauer TF, Beekman AT, Berger K, Blackwood DH, Boomsma DI, Breen G, Buttenschøn HN, Byrne EM, Cichon S, Clarke TK, Couvy-Duchesne B, Craddock N, de Geus EJ, Degenhardt F, Dunn EC, Edwards AC, Fanous AH, Forstner AJ, Frank J, Gill M, Gordon SD, Grabe HJ, Hamilton SP, Hardiman O, Hayward C, Heath AC, Henders AK, Herms S, Hickie IB, Hoffmann P, Homuth G, Hottenga JJ, Ising M, Jansen R, Kloiber S, Knowles JA, Lang M, Li QS, Lucae S, MacIntyre DJ, Madden PA, Martin NG, McGrath PJ, McGuffin P, McIntosh AM, Medland SE, Mehta D, Middeldorp CM, Milaneschi Y, Montgomery GW, Mors O, Müller-Myhsok B, Nauck M, Nyholt DR, Nöthen MM, Owen MJ, Penninx BW, Pergadia ML, Perlis RH, Peyrot WJ, Porteous DJ, Potash JB, Rice JP, Rietschel M, Riley BP, Rivera M, Schoevers R, Schulze TG, Shi J, Shyn SI, Smit JH, Smoller JW, Streit F, Strohmaier J, Teumer A, Treutlein J, Van der Auwera S, van Grootheest G, van Hemert AM, Völzke H, Webb BT, Weissman MM, Wellmann J, Willemsen G, Witt SH, Levinson DF, Lewis CM, Wray NR, Flint J, Sullivan PF, Kendler KS.Genetic effects influencing risk for major depressive disorder in China and Europe.Transl Psychiatry. 2017 Mar 28;7(3):e1074.
Harper DG, Jensen JE, Ravichandran C, Perlis RH, Fava M, Renshaw PF, Iosifescu DV.Tissue Type-Specific Bioenergetic Abnormalities in Adults with Major Depression. Neuropsychopharmacology. 2017 Mar;42(4):876-885.
Sellgren CM, Sheridan SD, Gracias J, Xuan D, Fu T, Perlis RH.Patient-specific models of microglia-mediated engulfment of synapses and neural progenitors.Mol Psychiatry. 2017 Feb; 22(2): 170–177.
McCoy TH, Castro V, Cagan A, Roberson AM, Perlis RH.Validation of a risk stratification tool for fall-related injury in a state-wide cohort. Brit Med J Open. 2017 Feb 6;7(2):e012189.
Barak-Corren Y, Castro VM, Javitt S, Hoffnagle AG, Dai Y, Perlis RH, Nock MK, Smoller JW, Reis BY.Predicting Suicidal Behavior From Longitudinal Electronic Health Records.Am J Psychiatry. 2017 Feb 1;174(2):154-162.
Charney AW, Ruderfer DM, Stahl EA, Moran JL, Chambert K, Belliveau RA, Forty L, Gordon-Smith K, Di Florio A, Lee PH, Bromet EJ, Buckley PF, Escamilla MA, Fanous AH, Fochtmann LJ, Lehrer DS, Malaspina D, Marder SR, Morley CP, Nicolini H, Perkins DO, Rakofsky JJ, Rapaport MH, Medeiros H, Sobell JL, Green EK, Backlund L, Bergen SE, Juréus A, Schalling M, Lichtenstein P, Roussos P, Knowles JA, Jones I, Jones LA, Hultman CM, Perlis RH, Purcell SM, McCarroll SA, Pato CN, Pato MT, Craddock N, Landén M, Smoller JW, Sklar P.Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder.Transl Psychiatry. 2017 Jan 10;7(1):e993.
Direk N, Williams S, Smith JA, Ripke S, Air T, Amare AT, Amin N, Baune BT, Bennett DA, Blackwood DH, Boomsma D, Breen G, Buttenschøn HN, Byrne EM, Børglum AD, Castelao E, Cichon S, Clarke TK, Cornelis MC, Dannlowski U, De Jager PL, Demirkan A, Domenici E, van Duijn CM, Dunn EC, Eriksson JG, Esko T, Faul JD, Ferrucci L, Fornage M, de Geus E, Gill M, Gordon SD, Grabe HJ, van Grootheest G, Hamilton SP, Hartman CA, Heath AC, Hek K, Hofman A, Homuth G, Horn C, Jan Hottenga J, Kardia SL, Kloiber S, Koenen K, Kutalik Z, Ladwig KH, Lahti J, Levinson DF, Lewis CM, Lewis G, Li QS, Llewellyn DJ, Lucae S, Lunetta KL, MacIntyre DJ, Madden P, Martin NG, McIntosh AM, Metspalu A, Milaneschi Y, Montgomery GW, Mors O, Mosley TH Jr, Murabito JM, Müller-Myhsok B, Nöthen MM, Nyholt DR, O'Donovan MC, Penninx BW, Pergadia ML, Perlis R, Potash JB, Preisig M, Purcell SM, Quiroz JA, Räikkönen K, Rice JP, Rietschel M, Rivera M, Schulze TG, Shi J, Shyn S, Sinnamon GC, Smit JH, Smoller JW, Snieder H, Tanaka T, Tansey KE, Teumer A, Uher R, Umbricht D, Van der Auwera S, Ware EB, Weir DR, Weissman MM, Willemsen G, Yang J, Zhao W, Tiemeier H, Sullivan PF.An Analysis of Two Genome-wide Association Meta-analyses Identifies a New Locus for Broad Depression Phenotype.Biol Psychiatry. 2016 Dec 8; S0006-3223(16)33068-2.
Bernhard RM, Chaponis J, Siburian R, Gallagher P, Ransohoff K, Wikler D, Perlis RH, Greene JD.Variation in the oxytocin receptor gene (OXTR) is associated with differences in moral judgment.Soc Cogn Affect Neurosci. 2016 Dec; 11(12):1872-1881.
Rumshisky A, Ghassemi M, Naumann T, Szolovits P, Castro VM, McCoy TH, Perlis RH.Predicting early psychiatric readmission with natural language processing of narrative discharge summaries.Transl Psychiatry. 2016 Oct 18;6(10):e921.
Perlis RH.Abandoning personalization to get to precision in the pharmacotherapy of depression. World Psychiatry. 2016 Oct; 15(3):228-235.
McCoy TH Jr, Castro VM, Roberson AM, Snapper LA, Perlis RH.Improving Prediction of Suicide and Accidental Death After Discharge From General Hospitals With Natural Language Processing.JAMA Psychiatry. 2016 Oct 1; 73(10):1064-1071.
McCoy TH Jr, Snapper L, Stern TA, Perlis RH.Underreporting of Delirium in Statewide Claims Data: Implications for Clinical Care and Predictive Modeling.Psychosomatics. 2016 Sep-Oct; 57(5):480-8.
Hyde CL, Nagle MW, Tian C, Chen X, Paciga SA, Wendland JR, Tung JY, Hinds DA, Perlis RH, Winslow AR.Identification of 15 genetic loci associated with risk of major depression in individuals of European descent. Nat Genet. 2016 Sep; 48(9):1031-6.
Song J, Bergen SE, Di Florio A, Karlsson R, Charney A, Ruderfer DM, Stahl EA; Members of the International Cohort Collection for Bipolar Disorder (ICCBD), Chambert KD, Moran JL, Gordon-Smith K, Forty L, Green EK, Jones I, Jones L, Scolnick EM, Sklar P, Smoller JW, Lichtenstein P, Hultman C, Craddock N, Landén M, Smoller JW, Perlis RH, Lee PH, Castro VM, Hoffnagle AG, Sklar P, Stahl EA, Purcell SM, Ruderfer DM, Charney AW, Roussos P, Michele Pato CP, Medeiros H, Sobel J, Craddock N, Jones I, Forty L, Florio AD, Green E, Jones L, Gordon-Smith K, Landen M, Hultman C, Jureus A, Bergen S, McCarroll S, Moran J, Smoller JW, Chambert K, Belliveau RA.Genome-wide association study identifies SESTD1 as a novel risk gene for lithium-responsive bipolar disorder.Mol Psychiatry. 2016 Sep;21(9):1290-7.
Liang SH, Chen JM, Normandin MD, Chang JS, Chang GC, Taylor CK, Trapa P, Plummer MS, Para KS, Conn EL, Lopresti-Morrow L, Lanyon LF, Cook JM, Richter KE, Nolan CE, Schachter JB, Janat F, Che Y, Shanmugasundaram V, Lefker BA, Enerson BE, Livni E, Wang L, Guehl NJ, Patnaik D, Wagner FF, Perlis R, Holson EB, Haggarty SJ, El Fakhri G, Kurumbail RG, Vasdev N.Discovery of a Highly Selective Glycogen Synthase Kinase-3 Inhibitor (PF-04802367) That Modulates Tau Phosphorylation in the Brain: Translation for PET Neuroimaging.Angew Chem Int Ed Engl. 2016 Aug 8; 55(33):9601-5.
Perlis RH.Autism and antidepressant use in pregnancy. J Pediatr. 2016 Jul; 174:278.
Haggarty SJ, Silva MC, Cross A, Brandon NJ, Perlis RH.Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.Mol Cell Neurosci. 2016 Jun;73:104-15.
Corral-Frías NS, Pizzagalli DA, Carré JM, Michalski LJ, Nikolova YS, Perlis RH, Fagerness J, Lee MR, Conley ED, Lancaster TM, Haddad S, Wolf A, Smoller JW, Hariri AR, Bogdan R.COMT Val(158) Met genotype is associated with reward learning: a replication study and meta-analysis.Genes Brain Behav. 2016 Jun;15(5):503-13.
Balekian DS, Linnemann RW, Castro VM, Perlis R, Thadhani R, Camargo CA Jr.Pre-birth cohort study of atopic dermatitis and severe bronchiolitis during infancy.Pediatr Allergy Immunol. 2016 Jun; 27(4):413-8.
Perlis RH, Perlis CS.Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs.PLoS One. 2016 May 16; 11(5):e0155474.
Venkatesh KK, Riley L, Castro VM, Perlis RH, Kaimal AJ.Association of Antenatal Depression Symptoms and Antidepressant Treatment With Preterm Birth.Obstet Gynecol. 2016 May; 127(5):926-33.
McGrath LM, Braaten EB, Doty ND, Willoughby BL, Wilson HK, O'Donnell EH, Colvin MK, Ditmars HL, Blais JE, Hill EN, Metzger A, Perlis RH, Willcutt EG, Smoller JW, Waldman ID, Faraone SV, Seidman LJ, Doyle AE.Extending the 'cross-disorder' relevance of executive functions to dimensional neuropsychiatric traits in youth. J Child Psychol Psychiatry. 2016 Apr;57(4):462-71.
Sylvia LG, Gold AK, Stange JP, Peckham AD, Deckersbach T, Calabrese JR, Weiss RD, Perlis RH, Nierenberg AA, Ostacher MJ. A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder.Am J Addict. 2016 Mar; 25(2):94-8.
Vöhringer PA, Perlis RH.Discriminating Between Bipolar Disorder and Major Depressive Disorder.Psychiatr Clin North Am. 2016 Mar; 39(1):1-10.
Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K, Akula N, Ardau R, Arias B, Backlund L, Banzato CE, Benabarre A, Bengesser S, Bhattacharjee AK, Biernacka JM, Birner A, Brichant-Petitjean C, Bui ET, Cervantes P, Chen GB, Chen HC, Chillotti C, Cichon S, Clark SR, Colom F, Cousins DA, Cruceanu C, Czerski PM, Dantas CR, Dayer A, Étain B, Falkai P, Forstner AJ, Frisén L, Fullerton JM, Gard S, Garnham JS, Goes FS, Grof P, Gruber O, Hashimoto R, Hauser J, Herms S, Hoffmann P, Hofmann A, Jamain S, Jiménez E, Kahn JP, Kassem L, Kittel-Schneider S, Kliwicki S, König B, Kusumi I, Lackner N, Laje G, Landén M, Lavebratt C, Leboyer M, Leckband SG, Jaramillo CA, MacQueen G, Manchia M, Martinsson L, Mattheisen M, McCarthy MJ, McElroy SL, Mitjans M, Mondimore FM, Monteleone P, Nievergelt CM, Nöthen MM, Ösby U, Ozaki N, Perlis RH, Pfennig A, Reich-Erkelenz D, Rouleau GA, Schofield PR, Schubert KO, Schweizer BW, Seemüller F, Severino G, Shekhtman T, Shilling PD, Shimoda K, Simhandl C, Slaney CM, Smoller JW, Squassina A, Stamm T, Stopkova P, Tighe SK, Tortorella A, Turecki G, Volkert J, Witt S, Wright A, Young LT, Zandi PP, Potash JB, DePaulo JR, Bauer M, Reininghaus EZ, Novák T, Aubry JM, Maj M, Baune BT, Mitchell PB, Vieta E, Frye MA, Rybakowski JK, Kuo PH, Kato T, Grigoroiu-Serbanescu M, Reif A, Del Zompo M, Bellivier F, Schalling M, Wray NR, Kelsoe JR, Alda M, Rietschel M, McMahon FJ, Schulze TG.Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study.Lancet. 2016 Mar 12; 387(10023):1085-93.
Roberson AM, Castro VM, Cagan A, Perlis RH.Antidepressant nonadherence in routine clinical settings determined from discarded blood samples.J Clin Psychiatry. 2016 Mar;77(3):359-62.
Castro VM, Roberson AM, McCoy TH, Wiste A, Cagan A, Smoller JW, Rosenbaum JF, Ostacher M, Perlis RH.Stratifying Risk for Renal Insufficiency Among Lithium-Treated Patients: An Electronic Health Record Study.Neuropsychopharmacology. 2016 Mar;41(4):1138-43.
Castro VM, Kong SW, Clements CC, Brady R, Kaimal AJ, Doyle AE, Robinson EB, Churchill SE, Kohane IS, Perlis RH.Absence of evidence for increase in risk for autism or attention-deficit hyperactivity disorder following antidepressant exposure during pregnancy: a replication study.Transl Psychiatry. 2016 Jan 5;6:e708.
Perlis RH.Getting Past Proof of Concept For New Treatments. Am J Psychiatry. 2015 Oct;172(10):937-8.
McCoy TH, Castro VM, Cagan A, Roberson AM, Kohane IS, Perlis RH.Sentiment Measured in Hospital Discharge Notes Is Associated with Readmission and Mortality Risk: An Electronic Health Record Study.PLos One. 2015 Aug 24; 10(8):e0136341.
Pavlova B, Perlis RH, Alda M, Uher R.Lifetime prevalence of anxiety disorders in people with bipolar disorder: a systematic review and meta-analysis.Lancet Psychiatry. 2015 Aug;2(8):710-7.
Uchida M, Spencer AE, Biederman J, Castro VM, Kenworthy T, Chan J, Rosales AM, Newton-Cheh C, Perlis RH.A Systematic Evaluation of the QTc Interval and Antidepressants in Youth: An Electronic Health Record Study.J Dev Behav Pediatr. 2015 Jul-Aug;36(6):434-9.
Arloth J, Bogdan R, Weber P, Frishman G, Menke A, Wagner KV, Balsevich G, Schmidt MV, Karbalai N, Czamara D, Altmann A, Trümbach D, Wurst W, Mehta D, Uhr M, Klengel T, Erhardt A, Carey CE, Conley ED, Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium (PGC), Ruepp A, Müller-Myhsok B, Hariri AR, Binder EB.Genetic Differences in the Immediate Transcriptome Response to Stress Predict Risk-Related Brain Function and Psychiatric Disorders.Neuron. 2015 Jun 3;86(5):1189-202.
Ostacher MJ, Perlis RH, Geddes J.Monotherapy Antidepressant Treatment is Not Associated With Mania in Bipolar I Disorder.Am J Psychiatry. 2015 Jun;172(6):586.
Ramos EM, Gillis T, Mysore JS, Lee JM, Alonso I, Gusella JF, Smoller JW, Sklar P, MacDonald ME, Perlis RH.Prevalence of Huntington's disease gene CAG trinucleotide repeat alleles in patients with bipolar disorder.Bipolar Disord. 2015 Jun;17(4):403-8.
Rotstein BH, Liang SH, Belov VV, Livni E, Levine DB, Bonab AA, Papisov MI, Perlis RH, Vasdev N.Practical Radiosynthesis and Preclinical Neuroimaging of [11C]isradipine, a Calcium Channel Antagonist.Molecules. 2015 May 26;20(6):9550-9.
Brennan FX, Gardner KR, Lombard J, Perlis RH, Fava M, Harris HW, Scott R.A Naturalistic Study of the Effectiveness of Pharmacogenetic Testing to Guide Treatment in Psychiatric Patients With Mood and Anxiety Disorders.Prim Care Companion CNS Discord. 2015 Apr 16; 17(2).
Uher R, Ripke S, Müller-Myhsok B, Lewis CM, Perlis RH.Association of a brain methylation site with clinical outcomes in depression does not replicate across populations.Am J Psychiatry. 2015 Apr;172(4):395-7.
Castro VM, Minnier J, Murphy SN, Kohane I, Churchill SE, Gainer V, Cai T, Hoffnagle AG, Dai Y, Block S, Weill SR, Nadal-Vicens M, Pollastri AR, Rosenquist JN, Goryachev S, Ongur D, Sklar P, Perlis RH, Smoller JW; International Cohort Collection for Bipolar Disorder Consortium.Validation of electronic health record phenotyping of bipolar disorder cases and controls.Am J Psychiatry. 2015 Apr;172(4):363-72.
McCoy TH, Castro VM, Rosenfield HR, Cagan A, Kohane IS, Perlis RH.A clinical perspective on the relevance of research domain criteria in electronic health records.Am J Psychiatry. 2015 Apr;172(4):316-20.
McCoy TH Jr, Perlis RH.A tool to utilize adverse effect profiles to identify brain-active medications for repurposing.Int J Neuropsychopharmacol.2015 Feb 11;18(3).
Center for Quantitative Health
Richard B. Simches Research Building
Contact us by emailDirections to Richard B. Simches Research Building185 Cambridge Street, Boston, MA 02114
Get Directions and View Larger Map
Back to Top